MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) EVP Thomas M. Ross sold 2,607 shares of MaxCyte stock in a transaction on Friday, March 31st. The stock was sold at an average price of $5.00, for a total transaction of $13,035.00. Following the transaction, the executive vice president now directly owns 333,197 shares in the company, valued […]
Related Keywords
Thomasm Ross , , Maxcyte Company Profile , Maxcyte Inc , Blackrock Inc , Vanguard Group Inc , Nasdaq , Millennium Management , Goldman Sachs Group Inc , Securities Exchange Commission , Get Rating , Exchange Commission , Water Life Science Advisors , Goldman Sachs Group , Sachs Group , Maxcyte Daily , Maxcyte , Nasdaq Mxct , Mxct , Medical , Insider Trading , Nsider Trades , Stocks ,
comparemela.com © 2020. All Rights Reserved.